全文获取类型
收费全文 | 13022篇 |
免费 | 1299篇 |
国内免费 | 159篇 |
专业分类
耳鼻咽喉 | 129篇 |
儿科学 | 278篇 |
妇产科学 | 303篇 |
基础医学 | 1162篇 |
口腔科学 | 89篇 |
临床医学 | 1434篇 |
内科学 | 1640篇 |
皮肤病学 | 122篇 |
神经病学 | 3238篇 |
特种医学 | 140篇 |
外科学 | 1276篇 |
综合类 | 1285篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 1308篇 |
眼科学 | 93篇 |
药学 | 922篇 |
21篇 | |
中国医学 | 689篇 |
肿瘤学 | 349篇 |
出版年
2024年 | 55篇 |
2023年 | 284篇 |
2022年 | 361篇 |
2021年 | 665篇 |
2020年 | 738篇 |
2019年 | 663篇 |
2018年 | 575篇 |
2017年 | 610篇 |
2016年 | 588篇 |
2015年 | 533篇 |
2014年 | 874篇 |
2013年 | 1216篇 |
2012年 | 701篇 |
2011年 | 800篇 |
2010年 | 608篇 |
2009年 | 606篇 |
2008年 | 678篇 |
2007年 | 599篇 |
2006年 | 488篇 |
2005年 | 425篇 |
2004年 | 352篇 |
2003年 | 304篇 |
2002年 | 254篇 |
2001年 | 177篇 |
2000年 | 158篇 |
1999年 | 111篇 |
1998年 | 104篇 |
1997年 | 111篇 |
1996年 | 96篇 |
1995年 | 84篇 |
1994年 | 65篇 |
1993年 | 54篇 |
1992年 | 64篇 |
1991年 | 48篇 |
1990年 | 53篇 |
1989年 | 41篇 |
1988年 | 37篇 |
1987年 | 33篇 |
1986年 | 36篇 |
1985年 | 42篇 |
1984年 | 30篇 |
1983年 | 18篇 |
1982年 | 31篇 |
1981年 | 32篇 |
1980年 | 13篇 |
1979年 | 17篇 |
1978年 | 13篇 |
1977年 | 14篇 |
1975年 | 4篇 |
1974年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
Hans-Jürgen Möller Horst Müller Richard L. Borison Nina R. Schooler Guy Chouinard 《European archives of psychiatry and clinical neuroscience》1995,245(1):45-49
The hypothesis that differences in drug effects of risperidone and haloperidol on negative symptoms in schizophrenia are secondary to effects on positive, extrapyramidal, and depressive symptoms was investigated by means of an analysis of the data from the USA-Canada risperidone double-blind randomized clinical trial of 523 chronic schizophrenic patients. Regression analyses in the total sample and within treatment groups confirmed a strong relationship between changes in negative symptoms and the other variables studied (R2=0.50–0.51,p<0.001). Only depressive symptoms did not contribute significantly to these results (p>0.10). Path analysis showed that the greater mean change (p<0.05) of negative symptoms with risperidone compared to haloperidol could not be fully explained by correlations with favourable effects on positive and extrapyramidal symptoms. The relationship between shift in extrapyramidal symptoms and shift in negative symptoms failed to reach statistical significance; however, there was a clear tendency in the expected direction in both treatment groups. 相似文献
32.
急性中风中脏腑证型与垂体-肾上腺轴激素关系的研究 总被引:6,自引:0,他引:6
目的 :探讨急性中风中脏腑证型与垂体—肾上腺轴激素的促肾上腺皮质激素 (ACTH)、皮质醇 (CS)的关系。方法 :对 78例中脏腑患者进行辨证分型 ,同时利用放射免疫分析 (RIA)法测定血中 ACTH、CS含量 ,按证型分为四组 ,对比不同证型间 ACTH、CS的水平 ,并与健康人组 (60例 )作对照。结果 :ACTH、CS含量水平比较 :1四种证型的 ACTH、CS均比正常健康人组高 (P <0 .0 0 1 ) ;2四种证型间比较有明显差异 (P<0 .0 1 ) ,从高到低为 :痰热内闭心窍证 >风火上扰清窍证 >痰湿蒙塞心神证 >元气败脱、心神散乱证。结论 :ACTH、CS含量水平可作为判别中脏腑不同证型间的微观指标 相似文献
33.
Jan E. Zejda Thomas S. Hurst Ernest M. Barber Charles Rhodes James A. Dosman 《American journal of industrial medicine》1993,23(5):743-750
A cross-sectional survey on respiratory health in swine producers showed that 30% of 301 examined men usually used a dust mask when working inside a barn. They did not differ significantly from dust mask nonusers in respect to respiratory symptoms and lung function. This analysis was undertaken to determine whether the respiratory health of dust mask users was associated with reasons why they had started individual respiratory protection. The subjects were recontacted in order to identify those who started using a mask to deliberately prevent symptoms (42 men) and those who started protection because of pre-existing respiratory symptoms (44 men). Not unexpectedly, betweengroup comparisons of respiratory symptoms and lung function suggest that swine producers who wear dust masks for preventive purposes have better respiratory health than those who wear dust masks because of symptoms or those who do not use individual respiratory protection. The individual reasons for starting dust mask usage should be examined among potential determinants of the outcomes of prospective studies which can then provide more valid assessment of the effect of individual respiratory protection. © 1993 Wiley-Liss, Inc. 相似文献
34.
H. -J. Möller H. M. van Praag B. Aufdembrinke P. Bailey T. R. E. Barnes J. Beck H. Bentsen F. X. Eich L. Farrow W. W. Fleischhacker J. Gerlach K. Grafford B. Hentschel A. Hertkorn S. Heylen Y. Lecrubier J. P. Leonard P. McKenna W. Maier V. Pedersen A. Rappard W. Rein J. Ryan M. Sloth Nielsen R. -D. Stieglitz G. Wegener J. Wilson 《Psychopharmacology》1994,115(1-2):221-228
There is little agreement about the methodology of clinical trials of antipsychotic drugs in patients with negative symptoms. A literature review revealed wide variation in experimental design, rating scales and study duration. This reflects differing views as to the definition and response to treatment of negative symptoms. Some degree of standardization would improve comparability of studies and aid the development of new compounds. Patients included in such studies should have displayed negative symptoms for at least 6 months. Depressive symptoms, positive schizophrenic symptoms and extrapyramidal signs may all influence or be confused with negative symptoms and may respond to treatment; they should be at a low level at baseline and should be measured during the study period. Studies should last at least 8 weeks. Several scales are available for measuring negative symptoms and are reviewed; a global impression score should be used additionally. 相似文献
35.
Twenty-four chronic schizophrenic long-stay hospital patients were identified, who had not received neuroleptic drugs for 8–30 (average 8 months) and met or exceeded a minimum criterion of severity of negative symptoms. They were rendomly alocated to either sulpiride 200 mg twice daily or matching placebo, on a double-blind basis for 12 weeks. The results showed that low-dose sulpiride was significantly better than placebo in relation to improvements in negative symptoms. The changes in social behaviour were complex and not obviously related to symptom improvement; exhibited abnormal behaviour, a major factor in preventing successful return to the community, consistently improved only on the active drug. 相似文献
36.
帕罗西汀对抑郁模型大鼠不同脑区环磷酸腺苷反应元件结合蛋白的影响 总被引:2,自引:0,他引:2
目的探讨帕罗西汀在不同用药时间对抑郁模型大鼠海马、前额叶皮质环磷酸腺苷反应元件结合蛋白(CREB)磷酸化(p-CREB)及总蛋白(t-CREB)水平的影响。方法成年雄性SpragueDawley大鼠36只,随机分为6组:对照组、抑郁模型组(以下简称模型组)、抑郁模型+用药1d组(以下简称用药1d组)、抑郁模型+用药1周组(以下简称用药1周组)、抑郁模型+用药2周组(以下简称用药2周组)和抑郁模型+用药4周组(以下简称用药4周组),每组各6只。抑郁模型的制作为强迫大鼠游泳4周,每天1次,每次15min。帕罗西汀的剂量为10m∥kg体质量,灌胃给药,时间分别为1d和1,2,4周,每天1次,于每次游泳前用药。采用Westernblot法检测各组大鼠海马及前额叶皮质的p-CREB和t-CREB水平。结果(1)模型组及用药1d、1周组大鼠海马p-CREB水平明显低于对照组(P〈0.01),用药2,4周组大鼠海马p-CREB水平与对照组的差异无统计学意义(P〉0.05);模型组及各用药组海马t-CREB水平与对照组的差异无统计学意义(P〉0.05)。(2)模型组及用药1d和1,2周组大鼠前额叶皮质p-CREB水平均明显低于对照组(P〈0.05),用药4周组与对照组的差异无统计学意义(P〉0.05)。模型组及用药1d、1周组大鼠前额叶皮质t-CREB水平与对照组的差异无统计学意义(P〉0.05),用药2,4周组大鼠前额叶皮质t-CREB水平均明显高于对照组(P〈0.05或P〈0.01)。结论慢性强迫游泳导致大鼠海马及前额叶皮质CREB活性降低,长期使用帕罗西汀可逆转此效应,提高抑郁大鼠前额叶皮质的CREB水平。 相似文献
37.
腕管综合征主要症状体征敏感性与特异性的比较 总被引:5,自引:1,他引:4
目的 比较腕管综合征 (carpaltunnelsyndrome ,CTS)主要症状、体征的敏感性与特异性。方法 对 10 1例 ( 162只手 )进行症状严重程度与功能状况的询问 ,感觉、运动功能的检查 ;其中 62只手在术后 6周再次测定。结果 162只患手中 15 8只具有典型症状 ( 98% )。Phalen征、前臂正中神经加压征、Semmes Weinstein单丝纤维测试阳性率分别为 98%、96%、82 %。 87%的患手出现肌力下降 ,拇短展肌肌力测定 (定量法 )结果显示 ,与徒手法相比 ,不同性别间、术前与术后的差异均具非常显著意义 (P <0 .0 1)。结论 典型症状、Phalen征、前臂正中神经加压征、拇短展肌肌力变化的敏感性与特异性最高 ,拇短展肌肌力定量法测定是判断腕管综合征严重程度、评定疗效的一个良好的客观指标。 相似文献
38.
目的 探讨SARS流行期间肺炎患者的临床表现和胸部影像变化特点。方法 对76例SARS流行期间发热留观室收治的肺炎患者的临床表现及胸部影像进行分析。结果 (1)此组肺炎患者多为青壮年(占60.53%),无固定职业或职业性质流动性较大者居多(69.74%);(2)临床特征主要是发热,以中高热为多见(80.26%),发病早期部分患者呼吸道症状并不明显(67.10%),外周血WBC在正常或低于正常范围(85.53%),淋巴细胞比例减少(75.00%);(3)肺部CT表现为不同程度的炎性浸润;病灶形态以斑片状和球形多见(77.63%);病灶常位于肺周边,常出现支气管气像;动态观察病变影像大多无明显进展(88.16%%),经治疗均完全吸收。结论 SARS流行期间普通肺炎与非典型肺炎有相似的临床及胸部影像表现;肺部CT扫描能早期发现肺炎患者的异常阴影,明显优于胸片,但无特异性。因此,在SARS流行期间发热诊室医务人员应加强肺部炎性改变的早期诊断和鉴别诊断水平。 相似文献
39.
G. Ransmayr W. Poewe S. Plörer F. Gerstenbrand K. Leidlmair U. Mayr 《Journal of neural transmission (Vienna, Austria : 1996)》1986,67(1-2):1-14
Summary Forty-four Parkinson patients (19 patients of the rigid-akinetic type, 13, of the rigid-akinetic-tremor type, and 12, of the tremor type) were included in a study in order to analyse correlations of the expression of the motor symptoms tremor, rigidity, akinesia, with other clinical parameters, computertomographic aspect of brain atrophy and psychometrically assessed cognitive parameters. Rigidity and akinesia are significantly positively correlated with the severity of motor dysability, stage of the disease, and brain atrophy, as is akinesia with a history of pharmacotoxic psychosis. Tremor is significantly negatively correlated with motor dysability, stage of the disease, and history of pharmacotoxic psychosis. Akinesia is correlated with visuomotor dysfunction (tested with Bender Gestalt Test) and rigidity with the depression score (Zung scale). The tremor type is favorable, the rigid-akinetic type unfavorable with respect to motor disability and psychosis. 相似文献
40.
Reeve Bryce B. Hays Ron D. Chang Chih-Hung Perfetto Eleanor M. 《Quality of life research》2007,16(1):1-8
Background Health-related quality of life (HRQL) is an accepted outcome measure in patients with mood and anxiety disorders. Yet, surprisingly
little attention has been paid to the determinants. In this paper we test the hypothesis that it is associated with personality
traits while controlling for mental disorders.
Methods A large sample of outpatients (n=640) with mood and anxiety disorders was studied. The empirically supported five factor model
of normal personality traits was assessed using the NEO-FFI and includes: neuroticism, extraversion, openness to experience,
agreeableness, and conscientiousness. Mental disorders were assessed with the CIDI, and HRQL with the SF-36.
Results Regression analyses revealed that the NEO-FFI scores, with the exception of conscientiousness, were significantly associated
with SF-36 subscales and summary scores, independently from the mental disorders. The percentage of explained variance due
to the personality traits was highest for the subscales Vitality (10.0%), Mental Health (13.3%) and the Mental Health Summary
Score (9.5%). Furthermore, specific personality traits were related to specific SF-36 subscales.
Conclusions A low HRQL of patients with mood or anxiety disorders is not only determined by the disease or the current health but is also
shaped by personality traits that are relatively stable throughout an individual's life time. 相似文献